The therapeutic application of the stable gastric pentadecapeptide BPC-157 to mitigate or resolve inflammatory processes occurring within the central and peripheral nervous systems. This targeted action is crucial for protecting neurons, supporting glial cell function, and promoting recovery following various forms of neurological insult or chronic stress. Controlling neuroinflammation is vital for maintaining cognitive integrity and mental health.
Origin
BPC-157 is a synthetic peptide derived from a fragment of human gastric juice protein BPC, originally studied for its remarkable healing properties in the gastrointestinal tract. The recognition of its systemic effects, particularly on the nervous system, expanded its application into neuropharmacology and regenerative medicine.
Mechanism
BPC-157 exerts its anti-inflammatory effects by modulating several key signaling pathways, including the nitric oxide (NO) system and the regulation of cytokine production by microglial cells. It promotes the survival of various cell types under stress and facilitates the repair of nerve tissue, potentially by interacting with growth factor pathways like the Vascular Endothelial Growth Factor (VEGF) system, thereby stabilizing the blood-brain barrier and reducing inflammatory cell infiltration.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.